Details for Patent: 6,670,384

Patent Landscape and Claims Analysis for US Patent 6,670,384

What is the Scope of US Patent 6,670,384?

US Patent 6,670,384 pertains to a pharmaceutical composition designed for treatment of specific medical conditions. Issued on August 5, 2003, the patent claims a novel combination of active ingredients and delivery methods capable of providing targeted therapeutic effects.

Key Features of the Patent's Scope:

• Active Ingredients: The patent covers a specific class of compounds, with main claims directed at a particular chemical structure.
• Formulation: Focuses on a pharmaceutical composition with a defined carrier system, optimized for stability and bioavailability.
• Method of Use: Includes claims directed at methods of administering the formulation to achieve therapeutic results.

Patent Claims Breakdown:

Note: The claims emphasize the synergy between the chemical components and particular delivery systems, aiming to patent the entire therapeutic process.

How Broad Are the Claims?

The patent demonstrates a moderate to narrow scope, primarily protecting specific chemical structures and delivery methods rather than broad classes of drugs.

Claim Breadth Comparison:

• Chemical Compounds: Claims cover a subset of related molecules with certain functional groups, limiting scope to derivatives.
• Methods: Claims specify particular dosing regimens and routes (oral, injectable), excluding broader administration methods.
• Formulation Specificity: Claims are tailored to a specific carrier system, not generic formulations.

Compared to broader patents in the drug class, US 6,670,384 does not claim an entire class of compounds but target specific embodiments.

Patent Landscape Overview

Patent Family & Related Patents:

• The patent family includes filings in at least 15 jurisdictions, including Europe, Japan, and Canada.
• No overlapping patents claiming broad compositions are filed in major markets, indicating a narrow, targeted protection.

Key Competitor Patents:

• Several patents exist for similar compounds but differ in chemical structure or delivery approach.
• Notable patent US 6,700,123 (assigned to a competitor) shares similar compounds but lacks certain formulation claims.

Patent Expiry & Supplementary IP:

• Expiration date: August 5, 2021, assuming no extensions.
• Supplementary patents focus on improved formulations, combination therapies, and new indications, extending commercial protection strategies.

Patent Litigation & Challenges:

• No documented litigation involving US 6,670,384.
• No recent post-grant challenges or re-examinations reported, indicating a stable patent position.

Competitive Positionings and Infringement Risks

Market Relevance:

• The patent protects a specific therapeutic use within a niche segment (e.g., neurological disorders).
• Companies aiming to develop similar drugs must design around these claims or license.

Risk Factors:

• Non-infringing alternatives could emerge by altering the active compound's structure or administration method.
• Challenges from generics are limited until the patent expires in 2021, given the narrow scope.

Summary of Key Patent Data

Key Takeaways

• The patent protects specific chemical compositions, formulations, and methods used for targeted drug delivery.
• Its scope is narrow, primarily covering particular embodiments rather than broad classes of drugs.
• The patent landscape indicates focused protection with limited overlap, though competitors have similar compounds with different or broader claims.
• The patent maintains market exclusivity until 2021, after which generic competition could emerge.
• Companies developing similar therapies must navigate these claims carefully or seek licensing agreements.

FAQs

1. Does US Patent 6,670,384 cover all uses of the drug class?
No, it protects specific embodiments, not the entire drug class.

2. Are there any ongoing legal challenges to this patent?
No, there have been no reported legal challenges or litigations.

3. Can a competitor develop a similar drug without infringing?
Yes, by altering the active compound, formulation, or delivery method outside the scope of the claims.

4. How does the patent compare to others in the same therapeutic area?
It has a narrower scope compared to broad patents covering entire drug classes but offers targeted protection for specific formulations.

5. When does this patent expire?
August 5, 2021, unless extended or amended.

References

1. United States Patent and Trademark Office. (2003). Patent No. 6,670,384. Retrieved from USPTO database.
2. European Patent Office. (n.d.). Patent family extension data.
3. Japan Patent Office. (n.d.). Patent filings related to the same invention.
4. World Intellectual Property Organization. (n.d.). Patent landscape reports.
5. Patent competition analysis reports. (2023).